---
layout: post
title: "Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine; Public Workshop; Request for Comments"
date: 2026-02-04 21:46:46 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-20658
original_published: 2025-11-24 00:00:00 +0000
significance: 8.00
---

# Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine; Public Workshop; Request for Comments

**Published:** February 04, 2026 21:46 UTC
**Source:** Federal Register
**Original Published:** November 24, 2025 00:00 UTC
**Document Number:** 2025-20658

## Summary

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine." The purpose of the public workshop is to initiate a discussion on expanding epinephrine accessibility and use, including in community settings, to reduce anaphylaxis-related morbidity and mortality. This public workshop will be convened and supported by a cooperative agreement between FDA and the Duke-Margolis Institute for Health Policy.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/11/24/2025-20658/improving-anaphylaxis-outcomes-approaches-for-enhancing-access-to-epinephrine-public-workshop)
- API: https://www.federalregister.gov/api/v1/documents/2025-20658

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
